INVA as of Nov 1 · 10:19 ET
INVANasdaqPharmaceutical Preparations

Innoviva, Inc. · Brief

Next report

3 days

Nov 4 · after closeest.Q3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±10.5%
avg realized
±3.0%
Nov 6 '24±11.0%▲+0.40%×0.04
Feb 26 '25±15.4%▼−1.96%×0.13
May 7 '25±22.9%▼−0.85%×0.04
Aug 6 '25±6.4%▲+1.15%×0.18
Q3 FY25±7.9%▲+12.89%×1.62
Q1 FY26±8.8%▼−2.89%×0.33
May 6 '26±6.2%▲+1.24%×0.20
Q2 FY26±5.8%▲+2.93%×0.51
quarterimplied−25%0+25%realized×
Q2 FY26±5.8%▲+2.93%×0.51
May '26±6.2%▲+1.24%×0.20
Q1 FY26±8.8%▼−2.89%×0.33
Q3 FY25±7.9%▲+12.89%×1.62
Aug '25±6.4%▲+1.15%×0.18
May '25±22.9%▼−0.85%×0.04
2 older reports
Feb '25±15.4%▼−1.96%×0.13
Nov '24±11.0%▲+0.40%×0.04
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2

12disclosed supplier and customer ties named in SEC filingsSEC filings
4tracked funds holding INVAN-PORT · Aug 31 '26

Bear2

10 of 24largest reporting managers that cut their stake in the latest quarter13F · Jun 30 '26
7 of 8recent reports where the move came in under the options implied rangeEarnings history
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

INVA report session

Customers 1

× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±21.5% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.